USD $847.57
ELOXATIN INJECTION is a potent chemotherapy medication used primarily in the treatment of colorectal cancer. It works by interfering with the growth and spread of cancer cells in the body, making it an essential component of combination therapy for patients diagnosed with advanced or metastatic colorectal cancer.
IndiaELOXATIN is an injectable chemotherapy medication that contains oxaliplatin, a platinum-based drug used primarily in the treatment of colorectal cancer. It works by interfering with the DNA in cancer cells, preventing them from dividing and growing.
ELOXATIN is indicated for the treatment of advanced colorectal cancer, often in combination with other chemotherapy agents. It may be used as a first-line treatment in patients with metastatic disease.
Oxaliplatin, the active ingredient in ELOXATIN, forms cross-links with DNA, leading to the inhibition of DNA synthesis and function. This action ultimately results in cancer cell death.
ELOXATIN is administered by a healthcare professional through intravenous (IV) infusion. The dosage and schedule depend on the specific treatment regimen and the patient's overall health.
Common side effects may include nausea, vomiting, diarrhea, fatigue, and peripheral neuropathy. It is important to discuss potential side effects with your healthcare provider before starting treatment.
Patients should inform their healthcare provider of any pre-existing conditions, allergies, or medications they are currently taking. Regular monitoring may be required during treatment to assess blood counts and liver function.
ELOXATIN should be stored at room temperature, away from light and moisture. Do not freeze. Keep out of reach of children.
ELOXATIN INJECTION is a vital component in the fight against colorectal cancer, offering hope and treatment options for patients. Always consult with a healthcare professional for personalized medical advice and treatment plans.
